|
|
Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.
Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.
People about to have surgery must tell their health care providers about all supplements they take.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.